Abivax
ABVX
Abivax (ABVX) news
Recent news
Perceptive Advisors reduces ASND, ENGN, Naut, ABVX in 2Q: 13F
Perceptive Advisors LLC, a hedge fund managed by Joseph Edelman, has disclosed its 13F filings for the first quarter of 2026, revealing several notable changes in its portfolio. Among the most significant adjustments are reductions in holdings of Ascendis Pharma A/S (ASND), enGene Holdings Inc.…
AInvest Wire · Aug 14, 2026Abivax shares up 3% at top of SBF120
AInvest Wire · Aug 7, 2026Valerio Therapeutics announces development collaboration with Abivax and provides pipeline update
AInvest Wire · Jul 16, 2026Abivax announces closing of $920 million public offering
AInvest Wire · Jul 6, 2026Abivax shares continue climbing after biotech firm moves to bolster balance sheet
AInvest Wire · Jul 2, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
